Liberty Wealth Management LLC Trims Holdings in Smith & Nephew plc (NYSE:SNN)

Liberty Wealth Management LLC lessened its holdings in Smith & Nephew plc (NYSE:SNN) by 35.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 808 shares of the medical equipment provider’s stock after selling 443 shares during the period. Liberty Wealth Management LLC’s holdings in Smith & Nephew were worth $32,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of SNN. Citigroup Inc. boosted its holdings in Smith & Nephew by 0.5% in the 4th quarter. Citigroup Inc. now owns 52,113 shares of the medical equipment provider’s stock worth $1,947,000 after buying an additional 261 shares during the period. Scotia Capital Inc. boosted its holdings in Smith & Nephew by 5.3% in the 4th quarter. Scotia Capital Inc. now owns 6,639 shares of the medical equipment provider’s stock valued at $248,000 after purchasing an additional 336 shares during the period. Commonwealth Equity Services LLC boosted its holdings in Smith & Nephew by 3.8% in the 4th quarter. Commonwealth Equity Services LLC now owns 11,678 shares of the medical equipment provider’s stock valued at $436,000 after purchasing an additional 432 shares during the period. MML Investors Services LLC boosted its holdings in Smith & Nephew by 3.9% in the 4th quarter. MML Investors Services LLC now owns 14,377 shares of the medical equipment provider’s stock valued at $537,000 after purchasing an additional 535 shares during the period. Finally, Eaton Vance Management boosted its holdings in Smith & Nephew by 14.4% in the 4th quarter. Eaton Vance Management now owns 6,472 shares of the medical equipment provider’s stock valued at $242,000 after purchasing an additional 815 shares during the period. Hedge funds and other institutional investors own 9.09% of the company’s stock.

Several brokerages have commented on SNN. Zacks Investment Research raised shares of Smith & Nephew from a “hold” rating to a “strong-buy” rating and set a $45.00 price target for the company in a report on Thursday, March 14th. BNP Paribas downgraded shares of Smith & Nephew from an “outperform” rating to a “neutral” rating in a report on Friday, February 8th. Finally, Canaccord Genuity lifted their price objective on shares of Smith & Nephew from $43.00 to $45.00 and gave the stock a “buy” rating in a report on Thursday, April 25th. Six equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Smith & Nephew currently has a consensus rating of “Hold” and an average target price of $25.50.

NYSE:SNN traded up $0.19 during trading hours on Friday, reaching $42.69. The company’s stock had a trading volume of 673,454 shares, compared to its average volume of 522,341. The stock has a market cap of $18.59 billion, a PE ratio of 21.13, a PEG ratio of 3.11 and a beta of 0.42. Smith & Nephew plc has a 1 year low of $32.22 and a 1 year high of $42.76. The company has a quick ratio of 1.15, a current ratio of 2.10 and a debt-to-equity ratio of 0.27.

The firm also recently announced a semiannual dividend, which was paid on Wednesday, May 8th. Investors of record on Friday, April 5th were given a $0.44 dividend. This represents a yield of 2.31%. The ex-dividend date was Thursday, April 4th. This is a boost from Smith & Nephew’s previous semiannual dividend of $0.25. Smith & Nephew’s dividend payout ratio (DPR) is presently 42.57%.

COPYRIGHT VIOLATION NOTICE: This news story was posted by Baseball Daily News and is the property of of Baseball Daily News. If you are viewing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright and trademark laws. The correct version of this news story can be read at https://www.baseballdailydigest.com/news/2019/05/11/liberty-wealth-management-llc-sells-443-shares-of-smith-nephew-plc-snn.html.

Smith & Nephew Company Profile

Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.

Further Reading: Real Estate Investment Trust (REIT) ETF

Institutional Ownership by Quarter for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.